Iambic Partners With Takeda To Accelerate Drug Design
Iambic and Takeda Pharmaceutical on Monday announced a multi-year partnership worth more than $1.7 billion to use AI in designing small-molecule drugs for cancer and gastrointestinal diseases. Under the deal Iambic will…